LOCUS       HBG2_HUMAN               147 aa            linear   PRI 12-SEP-2018
DEFINITION  RecName: Full=Hemoglobin subunit gamma-2; AltName:
            Full=Gamma-2-globin; AltName: Full=Hb F Ggamma; AltName:
            Full=Hemoglobin gamma-2 chain; AltName: Full=Hemoglobin gamma-G
            chain.
ACCESSION   P69892
VERSION     P69892.2
DBSOURCE    UniProtKB: locus HBG2_HUMAN, accession P69892;
            class: standard.
            extra accessions:A8MZE0,P02096,P62027,Q14491,Q68NH9,Q96FH6,Q96FH7
            created: Jul 21, 1986.
            sequence updated: Jan 23, 2007.
            annotation updated: Sep 12, 2018.
            xrefs: M91036.1, AAB59428.1, M91037.1, AAA58492.1, U01317.1,
            AAA16331.1, V00515.1, CAA23773.1, M15386.1, AAB50159.1, AY662983.1,
            AAT98611.1, AK290492.1, BAF83181.1, BC010914.1, AAH10914.1,
            BC029387.1, AAH29387.1, BC130457.1, AAI30458.1, BC130459.1,
            AAI30460.1, M11427.1, AAA35957.1, HGHUA, NP_000175.1, 1FDH_G,
            1FDH_H, 4MQJ_B, 4MQJ_D, 4MQJ_F, 4MQJ_H, 4MQK_B, 4MQK_D, 4MQK_F,
            4MQK_H
            xrefs (non-sequence databases): CCDS:CCDS7755.1, UniGene:Hs.302145,
            UniGene:Hs.702189, PDBsum:1FDH, PDBsum:4MQJ, PDBsum:4MQK,
            ProteinModelPortal:P69892, SMR:P69892, BioGrid:109298,
            ComplexPortal:CPX-2931, ComplexPortal:CPX-2933, CORUM:P69892,
            IntAct:P69892, MINT:P69892, STRING:9606.ENSP00000338082,
            iPTMnet:P69892, PhosphoSitePlus:P69892, BioMuta:HBG2,
            DMDM:56749861, EPD:P69892, MaxQB:P69892, PaxDb:P69892,
            PeptideAtlas:P69892, PRIDE:P69892, ProteomicsDB:57546,
            Ensembl:ENST00000336906, Ensembl:ENSP00000338082,
            Ensembl:ENSG00000196565, GeneID:3048, KEGG:hsa:3048,
            UCSC:uc001maj.2, CTD:3048, DisGeNET:3048,
            EuPathDB:HostDB:ENSG00000196565.12, GeneCards:HBG2, HGNC:4832,
            HPA:CAB016143, HPA:HPA043234, MalaCards:HBG2, MIM:142250,
            MIM:613977, neXtProt:NX_P69892, OpenTargets:ENSG00000196565,
            Orphanet:280615, Orphanet:46532, Orphanet:251380, PharmGKB:PA29207,
            eggNOG:KOG3378, eggNOG:COG1018, GeneTree:ENSGT00760000119197,
            HOVERGEN:HBG009709, InParanoid:P69892, KO:K13824, PhylomeDB:P69892,
            TreeFam:TF333268, Reactome:R-HSA-983231, SIGNOR:P69892,
            ChiTaRS:HBG2, EvolutionaryTrace:P69892, GeneWiki:HBG2,
            GenomeRNAi:3048, PRO:PR:P69892, Proteomes:UP000005640,
            Bgee:ENSG00000196565, CleanEx:HS_HBG2, ExpressionAtlas:P69892,
            Genevisible:P69892, GO:0072562, GO:0005829, GO:0005833, GO:0020037,
            GO:0046872, GO:0019825, GO:0005344, GO:0007596, CDD:cd08925,
            Gene3D:1.10.490.10, InterPro:IPR000971, InterPro:IPR009050,
            InterPro:IPR012292, InterPro:IPR002337, Pfam:PF00042,
            PRINTS:PR00814, SUPFAM:SSF46458, PROSITE:PS01033
KEYWORDS    3D-structure; Acetylation; Complete proteome; Direct protein
            sequencing; Disease mutation; Heme; Iron; Metal-binding; Oxygen
            transport; Phosphoprotein; Polymorphism; Reference proteome;
            S-nitrosylation; Transport.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 147)
  AUTHORS   Slightom,J.L., Blechl,A.E. and Smithies,O.
  TITLE     Human fetal G gamma- and A gamma-globin genes: complete nucleotide
            sequences suggest that DNA can be exchanged between these
            duplicated genes
  JOURNAL   Cell 21 (3), 627-638 (1980)
   PUBMED   7438203
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].
REFERENCE   2  (residues 1 to 147)
  AUTHORS   Cavallesco,C., Forget,B.G., deRiel,J.K., Wilson,L.B., Wilson,J.T.
            and Weissman,S.M.
  TITLE     Nucleotide sequence of human G gamma globin messenger RNA
  JOURNAL   Gene 12 (3-4), 215-221 (1980)
   PUBMED   7250702
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].
REFERENCE   3  (residues 1 to 147)
  AUTHORS   Kutlar,F., Shell,R.D., Elam,D., Holley,L., Nechtman,J. and
            Kutlar,A.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-JUN-2004)
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT M-CIRCLEVILLE LEU-64.
REFERENCE   4  (residues 1 to 147)
  AUTHORS   Ota,T., Suzuki,Y., Nishikawa,T., Otsuki,T., Sugiyama,T., Irie,R.,
            Wakamatsu,A., Hayashi,K., Sato,H., Nagai,K., Kimura,K., Makita,H.,
            Sekine,M., Obayashi,M., Nishi,T., Shibahara,T., Tanaka,T.,
            Ishii,S., Yamamoto,J., Saito,K., Kawai,Y., Isono,Y., Nakamura,Y.,
            Nagahari,K., Murakami,K., Yasuda,T., Iwayanagi,T., Wagatsuma,M.,
            Shiratori,A., Sudo,H., Hosoiri,T., Kaku,Y., Kodaira,H., Kondo,H.,
            Sugawara,M., Takahashi,M., Kanda,K., Yokoi,T., Furuya,T.,
            Kikkawa,E., Omura,Y., Abe,K., Kamihara,K., Katsuta,N., Sato,K.,
            Tanikawa,M., Yamazaki,M., Ninomiya,K., Ishibashi,T., Yamashita,H.,
            Murakawa,K., Fujimori,K., Tanai,H., Kimata,M., Watanabe,M.,
            Hiraoka,S., Chiba,Y., Ishida,S., Ono,Y., Takiguchi,S., Watanabe,S.,
            Yosida,M., Hotuta,T., Kusano,J., Kanehori,K., Takahashi-Fujii,A.,
            Hara,H., Tanase,T.O., Nomura,Y., Togiya,S., Komai,F., Hara,R.,
            Takeuchi,K., Arita,M., Imose,N., Musashino,K., Yuuki,H., Oshima,A.,
            Sasaki,N., Aotsuka,S., Yoshikawa,Y., Matsunawa,H., Ichihara,T.,
            Shiohata,N., Sano,S., Moriya,S., Momiyama,H., Satoh,N., Takami,S.,
            Terashima,Y., Suzuki,O., Nakagawa,S., Senoh,A., Mizoguchi,H.,
            Goto,Y., Shimizu,F., Wakebe,H., Hishigaki,H., Watanabe,T.,
            Sugiyama,A., Takemoto,M., Kawakami,B., Yamazaki,M., Watanabe,K.,
            Kumagai,A., Itakura,S., Fukuzumi,Y., Fujimori,Y., Komiyama,M.,
            Tashiro,H., Tanigami,A., Fujiwara,T., Ono,T., Yamada,K., Fujii,Y.,
            Ozaki,K., Hirao,M., Ohmori,Y., Kawabata,A., Hikiji,T., Kobatake,N.,
            Inagaki,H., Ikema,Y., Okamoto,S., Okitani,R., Kawakami,T.,
            Noguchi,S., Itoh,T., Shigeta,K., Senba,T., Matsumura,K.,
            Nakajima,Y., Mizuno,T., Morinaga,M., Sasaki,M., Togashi,T.,
            Oyama,M., Hata,H., Watanabe,M., Komatsu,T., Mizushima-Sugano,J.,
            Satoh,T., Shirai,Y., Takahashi,Y., Nakagawa,K., Okumura,K.,
            Nagase,T., Nomura,N., Kikuchi,H., Masuho,Y., Yamashita,R.,
            Nakai,K., Yada,T., Nakamura,Y., Ohara,O., Isogai,T. and Sugano,S.
  TITLE     Complete sequencing and characterization of 21,243 full-length
            human cDNAs
  JOURNAL   Nat. Genet. 36 (1), 40-45 (2004)
   PUBMED   14702039
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].;
            TISSUE=Brain
REFERENCE   5  (residues 1 to 147)
  AUTHORS   Gerhard,D.S., Wagner,L., Feingold,E.A., Shenmen,C.M., Grouse,L.H.,
            Schuler,G., Klein,S.L., Old,S., Rasooly,R., Good,P., Guyer,M.,
            Peck,A.M., Derge,J.G., Lipman,D., Collins,F.S., Jang,W., Sherry,S.,
            Feolo,M., Misquitta,L., Lee,E., Rotmistrovsky,K., Greenhut,S.F.,
            Schaefer,C.F., Buetow,K., Bonner,T.I., Haussler,D., Kent,J.,
            Kiekhaus,M., Furey,T., Brent,M., Prange,C., Schreiber,K.,
            Shapiro,N., Bhat,N.K., Hopkins,R.F., Hsie,F., Driscoll,T.,
            Soares,M.B., Casavant,T.L., Scheetz,T.E., Brown-stein,M.J.,
            Usdin,T.B., Toshiyuki,S., Carninci,P., Piao,Y., Dudekula,D.B.,
            Ko,M.S., Kawakami,K., Suzuki,Y., Sugano,S., Gruber,C.E.,
            Smith,M.R., Simmons,B., Moore,T., Waterman,R., Johnson,S.L.,
            Ruan,Y., Wei,C.L., Mathavan,S., Gunaratne,P.H., Wu,J., Garcia,A.M.,
            Hulyk,S.W., Fuh,E., Yuan,Y., Sneed,A., Kowis,C., Hodgson,A.,
            Muzny,D.M., McPherson,J., Gibbs,R.A., Fahey,J., Helton,E.,
            Ketteman,M., Madan,A., Rodrigues,S., Sanchez,A., Whiting,M.,
            Madari,A., Young,A.C., Wetherby,K.D., Granite,S.J., Kwong,P.N.,
            Brinkley,C.P., Pearson,R.L., Bouffard,G.G., Blakesly,R.W.,
            Green,E.D., Dickson,M.C., Rodriguez,A.C., Grimwood,J., Schmutz,J.,
            Myers,R.M., Butterfield,Y.S., Griffith,M., Griffith,O.L.,
            Krzywinski,M.I., Liao,N., Morin,R., Palmquist,D., Petrescu,A.S.,
            Skalska,U., Smailus,D.E., Stott,J.M., Schnerch,A., Schein,J.E.,
            Jones,S.J., Holt,R.A., Baross,A., Marra,M.A., Clifton,S.,
            Makowski,K.A., Bosak,S. and Malek,J.
  CONSRTM   MGC Project Team
  TITLE     The status, quality, and expansion of the NIH full-length cDNA
            project: the Mammalian Gene Collection (MGC)
  JOURNAL   Genome Res. 14 (10B), 2121-2127 (2004)
   PUBMED   15489334
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].;
            TISSUE=Bone marrow, Lung, and Placenta
            Erratum:[Genome Res. 2006 Jun;16(6):804. Morrin, Ryan [corrected to
            Morin, Ryan]]
REFERENCE   6  (residues 1 to 147)
  AUTHORS   SCHROEDER,W.A., SHELTON,J.R., SHELTON,J.B., CORMICK,J. and
            JONES,R.T.
  TITLE     THE AMINO ACID SEQUENCE OF THE GAMMA CHAIN OF HUMAN FETAL
            HEMOGLOBIN
  JOURNAL   Biochemistry 2, 992-1008 (1963)
   PUBMED   14087393
  REMARK    PROTEIN SEQUENCE OF 2-147.
REFERENCE   7  (residues 1 to 147)
  AUTHORS   Lubec,G., Afjehi-Sadat,L., Chen,W.-Q. and Sun,Y.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-DEC-2008) to UniProtKB
  REMARK    PROTEIN SEQUENCE OF 2-60; 67-77 AND 84-147, AND IDENTIFICATION BY
            MASS SPECTROMETRY.;
            TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex
REFERENCE   8  (residues 1 to 147)
  AUTHORS   Lang,K.M. and Spritz,R.A.
  TITLE     Cloning specific complete polyadenylylated 3'-terminal cDNA
            segments
  JOURNAL   Gene 33 (2), 191-196 (1985)
   PUBMED   2581851
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 122-147.
REFERENCE   9  (residues 1 to 147)
  AUTHORS   Burkard,T.R., Planyavsky,M., Kaupe,I., Breitwieser,F.P.,
            Burckstummer,T., Bennett,K.L., Superti-Furga,G. and Colinge,J.
  TITLE     Initial characterization of the human central proteome
  JOURNAL   BMC Syst Biol 5, 17 (2011)
   PUBMED   21269460
  REMARK    IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
            Publication Status: Online-Only
REFERENCE   10 (residues 1 to 147)
  AUTHORS   Zhou,H., Di Palma,S., Preisinger,C., Peng,M., Polat,A.N., Heck,A.J.
            and Mohammed,S.
  TITLE     Toward a comprehensive characterization of a human cancer cell
            phosphoproteome
  JOURNAL   J. Proteome Res. 12 (1), 260-271 (2013)
   PUBMED   23186163
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-51; SER-53;
            SER-140; SER-143 AND SER-144, AND IDENTIFICATION BY MASS
            SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Erythroleukemia
REFERENCE   11 (residues 1 to 147)
  AUTHORS   Frier,J.A. and Perutz,M.F.
  TITLE     Structure of human foetal deoxyhaemoglobin
  JOURNAL   J. Mol. Biol. 112 (1), 97-112 (1977)
   PUBMED   881729
  REMARK    X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 2-147 IN COMPLEX WITH
            HEME AND ALPHA CHAIN, AND SUBUNIT.
REFERENCE   12 (residues 1 to 147)
  AUTHORS   Stegink,L.D., Meyer,P.D. and Brummel,M.C.
  TITLE     Human fetal hemoglobin F 1. Acetylation status
  JOURNAL   J. Biol. Chem. 246 (9), 3001-3007 (1971)
   PUBMED   5554303
  REMARK    ACETYLATION AT GLY-2.
REFERENCE   13 (residues 1 to 147)
  AUTHORS   Cauchi,M.N., Clegg,J.B. and Weatherall,D.J.
  TITLE     Haemoglobin F(Malta): a new foetal haemoglobin variant with a high
            incidence in Maltese infants
  JOURNAL   Nature 223 (5203), 311-313 (1969)
   PUBMED   5792729
  REMARK    VARIANT MALTA-1 ARG-118.
REFERENCE   14 (residues 1 to 147)
  AUTHORS   Carrell,R.W., Owen,M.C., Anderson,R. and Berry,E.
  TITLE     Haemoglobin F auckland G gamma 7 Asp leads to Asn: further evidence
            for multiple genes for the gamma chain
  JOURNAL   Biochim. Biophys. Acta 365 (2), 323-327 (1974)
   PUBMED   4429671
  REMARK    VARIANT AUCKLAND ASN-8.
REFERENCE   15 (residues 1 to 147)
  AUTHORS   Brimhall,B., Vedvick,T.S., Jones,R.T., Ahern,E., Palomino,E. and
            Ahern,V.
  TITLE     Haemoglobin F Port Royal (alpha2G gamma2 125 Glu leads to Ala)
  JOURNAL   Br. J. Haematol. 27 (2), 313-318 (1974)
   PUBMED   4846278
  REMARK    VARIANT PORT-ROYAL ALA-126.
REFERENCE   16 (residues 1 to 147)
  AUTHORS   Eng,L.I., Kamuzora,H. and Lehmann,H.
  TITLE     Haemoglobin F Malaysia: alpha 2, gamma 2 1(NA1) glycine--cysteine;
            136 glycine
  JOURNAL   J. Med. Genet. 11 (1), 25-30 (1974)
   PUBMED   4837284
  REMARK    VARIANT MALAYSIA CYS-2.
REFERENCE   17 (residues 1 to 147)
  AUTHORS   Lee-Potter,J.P., Deacon-Smith,R.A., Simpkiss,M.J., Kamuzora,H. and
            Lehmann,H.
  TITLE     A new cause of haemolytic anaemia in the newborn. A description of
            an unstable fetal haemoglobin: F Poole, alpha2-G-gamma2 130
            trptophan yeilds glycine
  JOURNAL   J. Clin. Pathol. 28 (4), 317-320 (1975)
   PUBMED   1127124
  REMARK    VARIANT POOLE GLY-131.
REFERENCE   18 (residues 1 to 147)
  AUTHORS   Brennan,S.O., Smith,M.B. and Carrell,R.W.
  TITLE     Haemoglobin F Melbourne Ggamma 16 Gly leads to Arg and haemoglobin
            F carlton Ggamma 121 Glu leads to Lys. Further evidence for varied
            activity of gamma-chain genes
  JOURNAL   Biochim. Biophys. Acta 490 (2), 452-455 (1977)
   PUBMED   836882
  REMARK    VARIANTS MELBOURNE ARG-17 AND CARLTON LYS-122.
REFERENCE   19 (residues 1 to 147)
  AUTHORS   Ohta,Y., Saito,S., Fujita,S., Wilson,J.B., Lam,H. and Huisman,T.H.
  TITLE     Hb F-Meinohama or alpha 2 gamma 2 (5 Glu replaced by Gly; 75 Ile;
            136 Gly)
  JOURNAL   Hemoglobin 5 (6), 565-570 (1981)
   PUBMED   6172403
  REMARK    VARIANT MEINOHAMA GLY-6.
REFERENCE   20 (residues 1 to 147)
  AUTHORS   Honig,G.R., Koshy,M., Schroeder,W.A., Shelton,J.B. and Shelton,J.R.
  TITLE     Hemoglobin F Lodz (G gamma I 44 Ser replaced by Arg). A newly
            identified variant from an American infant of Polish descent
  JOURNAL   Biochim. Biophys. Acta 707 (2), 213-216 (1982)
   PUBMED   6814491
  REMARK    VARIANT LODZ ARG-45.
REFERENCE   21 (residues 1 to 147)
  AUTHORS   Serjeant,G.R., Serjeant,B.E., Lehmann,H., Dukes,M. and Robb,L.
  TITLE     Hb F Kingston (G gamma 55 [D6] Met leads to Arg)
  JOURNAL   FEBS Lett. 150 (1), 77-80 (1982)
   PUBMED   6186522
  REMARK    VARIANT KINGSTON ARG-56.
REFERENCE   22 (residues 1 to 147)
  AUTHORS   Shelton,J.B., Shelton,J.R., Espinueva,Z., Huynh,V., Schroeder,W.A.
            and Powars,D.
  TITLE     Hemoglobin F-Caltech: alpha 2 G gamma 2 120Lys replaced by Gln
  JOURNAL   Hemoglobin 6 (6), 577-592 (1982)
   PUBMED   6186635
  REMARK    VARIANT CALTECH GLN-121.
REFERENCE   23 (residues 1 to 147)
  AUTHORS   Nakatsuji,T., Lam,H., Wilson,J.B., Webber,B.B. and Huisman,T.H.
  TITLE     Hb F-Columbus-Ga or alpha 2 G gamma 2 94(FGl) Asp replaced by Asn
  JOURNAL   Hemoglobin 6 (6), 593-598 (1982)
   PUBMED   6186636
  REMARK    VARIANT COLUMBUS-GA ASN-95.
REFERENCE   24 (residues 1 to 147)
  AUTHORS   Nakatsuji,T., Lam,H. and Huisman,T.H.
  TITLE     Hb F-Kennestone or alpha 2G gamma 2 (EF1)77 His leads to Arg
            observed in a Caucasian baby
  JOURNAL   Hemoglobin 7 (3), 267-270 (1983)
   PUBMED   6192110
  REMARK    VARIANT KENNESTONE ARG-78.
REFERENCE   25 (residues 1 to 147)
  AUTHORS   Nakatsuji,T., Shimizu,K. and Huisman,T.H.
  TITLE     Hb F-La Grange or alpha 2 gamma 2 101(G3)Glu----Lys; 75Ile; 136Gly:
            a high oxygen affinity fetal hemoglobin variant observed in a
            Caucasian newborn
  JOURNAL   Biochim. Biophys. Acta 789 (2), 224-228 (1984)
   PUBMED   6206897
  REMARK    VARIANT LA GRANGE LYS-102.
REFERENCE   26 (residues 1 to 147)
  AUTHORS   Zeng,Y.T., Huang,S.Z., Nakatsuji,T. and Huisman,T.H.
  TITLE     -G gamma A gamma-Thalassemia and gamma-chain variants in Chinese
            newborn babies
  JOURNAL   Am. J. Hematol. 18 (3), 235-242 (1985)
   PUBMED   2579547
  REMARK    VARIANT SHANGHAI ARG-67.
REFERENCE   27 (residues 1 to 147)
  AUTHORS   Chen,S., Wilson,J.B., Webber,B.B., Huisman,T.H., Miwa,S. and
            Amenomori,Y.
  TITLE     Hb F-Tokyo or alpha 2G gamma 2 34(B16)Val----Ile, a silent gamma
            chain variant detected by reverse phase high performance liquid
            chromatography
  JOURNAL   Hemoglobin 9 (1), 25-32 (1985)
   PUBMED   2581919
  REMARK    VARIANT TOKYO ILE-35.
REFERENCE   28 (residues 1 to 147)
  AUTHORS   Hu,H.Y. and Ma,M.S.
  TITLE     Hb F-Urumqi G gamma I22(B4)Asp----Gly: a new fetal hemoglobin
            variant found in a Uygur baby
  JOURNAL   Hemoglobin 10 (1), 15-20 (1986)
   PUBMED   2420748
  REMARK    VARIANT URUMQI GLY-23.
REFERENCE   29 (residues 1 to 147)
  AUTHORS   de Pablos,J.M., Wilson,J.B., Kutlar,A., Chen,S.S. and Huisman,T.H.
  TITLE     Hb F-Albaicin or G gamma 8(A5)Lys----Glu or Gln
  JOURNAL   Hemoglobin 10 (6), 655-659 (1986)
   PUBMED   2435680
  REMARK    VARIANTS ALBAICIN GLU-9 AND GLN-9.
REFERENCE   30 (residues 1 to 147)
  AUTHORS   Hayashi,A., Wada,Y., Matsuo,T., Katakuse,I. and Matsuda,H.
  TITLE     Neonatal screening and mass-spectrometric analysis of hemoglobin
            variants in Japan
  JOURNAL   Acta Haematol. 78 (2-3), 114-118 (1987)
   PUBMED   3120456
  REMARK    VARIANTS FUCHU GLN-22 AND MINOO ARG-73.
REFERENCE   31 (residues 1 to 147)
  AUTHORS   Kleman,K., Lubin,B., Wilson,J.B., Kutlar,A., Webber,B.B. and
            Huisman,T.H.
  TITLE     Hb F-Oakland or alpha 2G gamma I2(26)(B8)Glu----Lys
  JOURNAL   Hemoglobin 11 (2), 181-183 (1987)
   PUBMED   2442122
  REMARK    VARIANT OAKLAND LYS-27.
REFERENCE   32 (residues 1 to 147)
  AUTHORS   Kutlar,A., Kutlar,F., Wilson,J.B., Webber,B.B., Gonzalez
            Redondo,J.M. and Huisman,T.H.
  TITLE     Hb F-Clarke or alpha 2G gamma 2(65)(E9)Lys----Asn
  JOURNAL   Hemoglobin 11 (2), 185-188 (1987)
   PUBMED   2442123
  REMARK    VARIANT CLARKE ASN-66.
REFERENCE   33 (residues 1 to 147)
  AUTHORS   de Pablos,J.M. and Clegg,J.B.
  TITLE     Hb F-Granada or alpha 2G gamma (2)22(B4)Asp----Val: a new human
            fetal hemoglobin variant
  JOURNAL   Hemoglobin 12 (4), 405-407 (1988)
   PUBMED   2459082
  REMARK    VARIANT GRANADA VAL-23.
REFERENCE   34 (residues 1 to 147)
  AUTHORS   Kutlar,A., Kutlar,F., Wilson,J.B., Webber,B.B., Hu,H. and
            Huisman,T.H.
  TITLE     Hb F-Austell or alpha 2G gamma (2)40(C6)Arg----Lys
  JOURNAL   Hemoglobin 12 (4), 409-411 (1988)
   PUBMED   2459083
  REMARK    VARIANT AUSTELL LYS-41.
REFERENCE   35 (residues 1 to 147)
  AUTHORS   Glader,B.E., Zwerdling,D., Kutlar,F., Kutlar,A., Wilson,J.B. and
            Huisman,T.H.
  TITLE     Hb F-M-Osaka or alpha 2G gamma 2(63)(E7)His----Tyr in a Caucasian
            male infant
  JOURNAL   Hemoglobin 13 (7-8), 769-773 (1989)
   PUBMED   2483933
  REMARK    VARIANT TNCY TYR-64.
REFERENCE   36 (residues 1 to 147)
  AUTHORS   Priest,J.R., Watterson,J., Jones,R.T., Faassen,A.E. and
            Hedlund,B.E.
  TITLE     Mutant fetal hemoglobin causing cyanosis in a newborn
  JOURNAL   Pediatrics 83 (5), 734-736 (1989)
   PUBMED   2470017
  REMARK    VARIANT TNCY TYR-93.
REFERENCE   37 (residues 1 to 147)
  AUTHORS   Plaseska,D., Li,H.J., Wilson,J.B., Kutlar,F., Kutlar,A.,
            Huisman,T.H. and Kulpa,J.
  TITLE     Hb F-Brooklyn or alpha 2G gamma 2(66)(E10)Lys----Gln
  JOURNAL   Hemoglobin 14 (2), 213-216 (1990)
   PUBMED   1703138
  REMARK    VARIANT BROOKLYN GLN-67.
REFERENCE   38 (residues 1 to 147)
  AUTHORS   Harano,T., Harano,K., Doi,K., Ueda,S., Imai,K., Ohba,Y., Kutlar,F.
            and Huisman,T.H.
  TITLE     Hb F-Onoda or alpha 2G gamma 2(146)(HC3)His----Tyr, a newly
            discovered fetal hemoglobin variant in a Japanese newborn
  JOURNAL   Hemoglobin 14 (2), 217-222 (1990)
   PUBMED   1703139
  REMARK    VARIANT ONODA TYR-147.
REFERENCE   39 (residues 1 to 147)
  AUTHORS   Plaseska,D., Wilson,J.B., Kutlar,F., Font,L., Baiget,M. and
            Huisman,T.H.
  TITLE     Hb F-Catalonia or alpha 2G gamma(2)15(A12)Trp----Arg
  JOURNAL   Hemoglobin 14 (5), 511-516 (1990)
   PUBMED   1706691
  REMARK    VARIANT CATALONIA ARG-16.
REFERENCE   40 (residues 1 to 147)
  AUTHORS   Plaseska,D., Kutlar,F., Wilson,J.B., Fei,Y.J. and Huisman,T.H.
  TITLE     Hb F-Charlotte, an A gamma variant with a threonine residue in
            position gamma 75 and a glycine residue in position gamma 136
  JOURNAL   Hemoglobin 14 (6), 617-625 (1990)
   PUBMED   1714434
  REMARK    VARIANT CHARLOTTE THR-76.
REFERENCE   41 (residues 1 to 147)
  AUTHORS   Qualtieri,A., Crescibene,L., Bagala,A., De Marco,E.V., Bria,M. and
            Brancati,C.
  TITLE     Hb F-Cosenza or G gamma 25(B7)Gly----Glu: a new fast-moving fetal
            hemoglobin variant
  JOURNAL   Hemoglobin 15 (6), 509-515 (1991)
   PUBMED   1726095
  REMARK    VARIANT COSENZA GLU-26.
REFERENCE   42 (residues 1 to 147)
  AUTHORS   Pobedimskaya,D.D., Molchanova,T.P., Huisman,T.H., Harding,S.R. and
            Bakanec,R.
  TITLE     Hb F-Saskatoon or alpha 2G gamma (2)21(B3)Glu-->Lys observed in a
            North American Indian newborn
  JOURNAL   Hemoglobin 17 (6), 547-549 (1993)
   PUBMED   8144355
  REMARK    VARIANT SASKATOON LYS-22.
REFERENCE   43 (residues 1 to 147)
  AUTHORS   Plaseska,D., Panovska-Popovska,S., Lazarevski,M. and Efremov,G.D.
  TITLE     Hb F-Macedonia-II [G gamma 104(G6)Lys-->Asn]: a new gamma chain
            variant
  JOURNAL   Hemoglobin 18 (6), 373-382 (1994)
   PUBMED   7713741
  REMARK    VARIANT MACEDONIA-II ASN-105.
REFERENCE   44 (residues 1 to 147)
  AUTHORS   Kohli-Kumar,M., Zwerdling,T. and Rucknagel,D.L.
  TITLE     Hemoglobin F-Cincinnati, alpha 2G gamma 2 41(C7) Phe-->Ser in a
            newborn with cyanosis
  JOURNAL   Am. J. Hematol. 49 (1), 43-47 (1995)
   PUBMED   7741137
  REMARK    VARIANT TNCY SER-42.
REFERENCE   45 (residues 1 to 147)
  AUTHORS   Abbes,S., Fitzgerald,P.A., Varady,E., Girot,R., Pic,P.,
            Blouquit,Y., Ducrocq,R., Drupt,F. and Wajcman,H.
  TITLE     Two fetal hemoglobin variants affecting the same residue: Hb
            F-Emirates [G gamma 59(E3)Lys-->Glu] and Hb F-Sacromonte [G gamma
            59(E3)Lys-->Gln]
  JOURNAL   Hemoglobin 19 (3-4), 173-182 (1995)
   PUBMED   7558873
  REMARK    VARIANTS EMIRATES GLU-60 AND SACROMONTE GLN-60.
REFERENCE   46 (residues 1 to 147)
  AUTHORS   de Pablos Gallego,J.M., Gu,L.H., Leonova,J.Ye. and Huisman,T.H.
  TITLE     Hb F-Veleta or alpha 2 G gamma(2)40(C6)Arg-->Gly
  JOURNAL   Hemoglobin 19 (6), 407-411 (1995)
   PUBMED   8718700
  REMARK    VARIANT VELETA GLY-23.
REFERENCE   47 (residues 1 to 147)
  AUTHORS   Gu,L.H., Oner,C. and Huisman,T.H.
  TITLE     The G gamma T chain (G gamma 75 Thr; 136 Gly) in Hb F-Charlotte is
            the product of an A gamma gene with a limited gene conversion and
            that in Hb F-Waynesboro of a mutated G gamma gene
  JOURNAL   Hemoglobin 19 (6), 413-418 (1995)
   PUBMED   8718701
  REMARK    VARIANT WAYNESBORO THR-76.
REFERENCE   48 (residues 1 to 147)
  AUTHORS   Papadakis,M.N., Patrinos,G.P., Drakoulakou,O. and
            Loutradi-Anagnostou,A.
  TITLE     HbF-Lesvos: an HbF variant due to a novel G gamma mutation (:G
            gamma 75 ATA-->ACA) detected in a Greek family
  JOURNAL   Hum. Genet. 97 (2), 260-262 (1996)
   PUBMED   8566966
  REMARK    VARIANT LESVOS THR-76.
REFERENCE   49 (residues 1 to 147)
  AUTHORS   Manca,L., Cherchi,L., De Rosa,M.C., Giardina,B. and Masala,B.
  TITLE     A new, electrophoretically silent, fetal hemoglobin variant: Hb
            F-Calabria [Ggamma118(GH1)Phe-->Leu]
  JOURNAL   Hemoglobin 24 (1), 37-44 (2000)
   PUBMED   10722114
  REMARK    VARIANT CALABRIA LEU-119.
REFERENCE   50 (residues 1 to 147)
  AUTHORS   Wajcman,H., Borensztajn,K., Riou,J., Prome,D., Hurtrel,D.,
            Bardakdjian,J., Lena-Russo,D., Amouroux,I. and Ducrocq,R.
  TITLE     Two new Ggamma chain variants: Hb F-clamart [gamma17(A14)Lys-->Asn]
            and Hb F-Ouled Rabah [gamma19(B1)Asn-->Lys]
  JOURNAL   Hemoglobin 24 (1), 45-52 (2000)
   PUBMED   10722115
  REMARK    VARIANTS CLAMART ASN-18 AND OULED RABAH LYS-20.
REFERENCE   51 (residues 1 to 147)
  AUTHORS   Wajcman,H., Yapo,A.P., Riou,J., Prome,D., Richelme-David,S.,
            Hurtrel,D. and Bardakdjian-Michau,J.
  TITLE     A new Ggamma chain variant: Hb F-Coignieres [gamma75(E19)Ile-->Val]
  JOURNAL   Hemoglobin 25 (4), 425-428 (2001)
   PUBMED   11791877
  REMARK    VARIANT COIGNERES VAL-76.
REFERENCE   52 (residues 1 to 147)
  AUTHORS   Van den Driessche,M., Moerman,J., Moens,M., Van Eldere,S.,
            Derclaye,I. and Philippe,M.
  TITLE     Severe hereditary haemolytic anaemia in a Caucasian newborn: a new
            fetal haemoglobin variant Hb F-Bonheiden ((G)gamma 38(C4)
            Thr-->Pro)
  JOURNAL   Eur. J. Pediatr. 164 (4), 261-262 (2005)
   PUBMED   15645283
  REMARK    VARIANT BONHEIDEN PRO-39.
REFERENCE   53 (residues 1 to 147)
  AUTHORS   Lacan,P., Burnichon,N., Becchi,M., Zanella-Cleon,I., Aubry,M.,
            Couprie,N. and Francina,A.
  TITLE     A new G(gamma) chain variant: Hb F-Bron [gamma20(B2)val-->Ala]
  JOURNAL   Hemoglobin 29 (4), 301-305 (2005)
   PUBMED   16370494
  REMARK    VARIANT BRON ALA-21.
REFERENCE   54 (residues 1 to 147)
  AUTHORS   Dainer,E., Shell,R., Miller,R., Atkin,J.F., Pastore,M., Kutlar,A.,
            Zhuang,L., Holley,L., Davis,D.H. and Kutlar,F.
  TITLE     Neonatal cyanosis due to a novel fetal hemoglobin: Hb F-Circleville
            [Ggamma63(E7)His-->Leu, CAT>CTT]
  JOURNAL   Hemoglobin 32 (6), 596-600 (2008)
   PUBMED   19065339
  REMARK    VARIANT TNCY LEU-64, AND CHARACTERIZATION OF VARIANT TNCY TYR-64.
REFERENCE   55 (residues 1 to 147)
  AUTHORS   Crowley,M.A., Mollan,T.L., Abdulmalik,O.Y., Butler,A.D.,
            Goodwin,E.F., Sarkar,A., Stolle,C.A., Gow,A.J., Olson,J.S. and
            Weiss,M.J.
  TITLE     A hemoglobin variant associated with neonatal cyanosis and anemia
  JOURNAL   N. Engl. J. Med. 364 (19), 1837-1843 (2011)
   PUBMED   21561349
  REMARK    VARIANT TNCY MET-68, AND CHARACTERIZATION OF VARIANT TNCY MET-68.
            Erratum:[N Engl J Med. 2011 Jul 21;365(3):281]
REFERENCE   56 (residues 1 to 147)
  AUTHORS   Saller,E., Kohne,E., Dutly,F. and Frischknecht,H.
  TITLE     A new (G)gamma-globin variant causing low oxygen affinity: Hb
            F-Brugine/Feldkirch [(G)gamma105(G7)Leu-->His; HBG2: c.317T>A]
  JOURNAL   Hemoglobin 38 (2), 84-87 (2014)
   PUBMED   24502349
  REMARK    VARIANT TNCY HIS-106, AND CHARACTERIZATION OF VARIANT TNCY HIS-106.
COMMENT     On or before Jun 15, 2010 this sequence version replaced
            gi:74739836, gi:74760821, gi:74748321.
            [FUNCTION] Gamma chains make up the fetal hemoglobin F, in
            combination with alpha chains.
            [SUBUNIT] Heterotetramer of two alpha chains and two gamma chains
            in fetal hemoglobin (Hb F). {ECO:0000269|PubMed:881729}.
            [INTERACTION] Q6B0K9:HBM; NbExp=4; IntAct=EBI-3910089,
            EBI-12805802.
            [TISSUE SPECIFICITY] Red blood cells.
            [DEVELOPMENTAL STAGE] Expressed until four or five weeks after
            birth.
            [PTM] Acetylation of Gly-2 converts Hb F to the minor Hb F1.
            {ECO:0000269|PubMed:5554303}.
            [DISEASE] Cyanosis transient neonatal (TNCY) [MIM:613977]: A
            disorder characterized by cyanosis in the fetus and neonate, due to
            a defect in the fetal hemoglobin chain which has reduced affinity
            for oxygen. Some patients develop anemia resulting from increased
            destruction of red cells containing abnormal or unstable
            hemoglobin. The cyanosis resolves spontaneously by 5 to 6 months of
            age or earlier, as the adult beta-globin chain is produced and
            replaces the fetal gamma-globin chain.
            {ECO:0000269|PubMed:19065339, ECO:0000269|PubMed:21561349,
            ECO:0000269|PubMed:24502349, ECO:0000269|PubMed:2470017,
            ECO:0000269|PubMed:2483933, ECO:0000269|PubMed:7741137}. Note=The
            disease is caused by mutations affecting the gene represented in
            this entry.
            [SIMILARITY] Belongs to the globin family.
            {ECO:0000255|PROSITE-ProRule:PRU00238}.
            [SEQUENCE CAUTION] Sequence=AAB50159.1; Type=Erroneous initiation;
            Note=Translation N-terminally shortened.; Evidence={ECO:0000305}.
            [WEB RESOURCE] Name=HbVar; Note=Human hemoglobin variants and
            thalassemias;
            URL='http://globin.bx.psu.edu/cgi-
            bin/hbvar/query_vars3?mode=directlink&gene=HBG2'.
FEATURES             Location/Qualifiers
     source          1..147
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
     gene            1..147
                     /gene="HBG2"
     Protein         1..147
                     /product="Hemoglobin subunit gamma-2"
                     /note="Gamma-2-globin; Hb F Ggamma; Hemoglobin gamma-2
                     chain; Hemoglobin gamma-G chain"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          2..147
                     /region_name="Mature chain"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Hemoglobin subunit gamma-2. /FTId=PRO_0000053254."
     Region          2
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="G -> C (in Malaysia; dbSNP:rs36006195).
                     {ECO:0000269|PubMed:4837284}. /FTId=VAR_003123."
     Site            2
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N-acetylglycine; in form Hb F1.
                     {ECO:0000269|PubMed:5554303}."
     Region          6..18
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          6
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="E -> G (in Meinohama; dbSNP:rs34263826).
                     {ECO:0000269|PubMed:6172403}. /FTId=VAR_003126."
     Region          7..146
                     /region_name="Hb-beta_like"
                     /note="Hemoglobin beta, gamma, delta, epsilon, and related
                     Hb subunits; cd08925"
                     /db_xref="CDD:271276"
     Region          8
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="D -> N (in Auckland; dbSNP:rs34501593).
                     {ECO:0000269|PubMed:4429671}. /FTId=VAR_003129."
     Region          9
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> E (in Albaicin; dbSNP:rs35521813).
                     {ECO:0000269|PubMed:2435680}. /FTId=VAR_020643."
     Region          9
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> Q (in Albaicin; dbSNP:rs35521813).
                     {ECO:0000269|PubMed:2435680}. /FTId=VAR_020644."
     Region          13
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="T -> R (in Heather; dbSNP:rs281864890).
                     /FTId=VAR_020645."
     Site            13
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphothreonine. {ECO:0000250|UniProtKB:P68871}."
     Region          16
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="W -> R (in Catalonia; dbSNP:rs34438981).
                     {ECO:0000269|PubMed:1706691}. /FTId=VAR_003131."
     Region          17
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="G -> R (in Melbourne; dbSNP:rs34907654).
                     {ECO:0000269|PubMed:836882}. /FTId=VAR_003132."
     Region          18
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> N (in Clamart; dbSNP:rs35621390).
                     {ECO:0000269|PubMed:10722115}. /FTId=VAR_020646."
     Region          20
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N -> K (in Ouled Rabah; dbSNP:rs34018799).
                     {ECO:0000269|PubMed:10722115}. /FTId=VAR_020647."
     Region          21..35
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          21
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="V -> A (in Bron; dbSNP:rs63751196).
                     {ECO:0000269|PubMed:16370494}. /FTId=VAR_030496."
     Region          22
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="E -> K (in Saskatoon; dbSNP:rs33955330).
                     {ECO:0000269|PubMed:8144355}. /FTId=VAR_003133."
     Region          22
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="E -> Q (in Fuchu; dbSNP:rs33955330).
                     {ECO:0000269|PubMed:3120456}. /FTId=VAR_003134."
     Region          23
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="D -> G (in Urumqi; dbSNP:rs281864891).
                     {ECO:0000269|PubMed:2420748, ECO:0000269|PubMed:8718700}.
                     /FTId=VAR_020648."
     Region          23
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="D -> V (in Granada; dbSNP:rs281864891).
                     {ECO:0000269|PubMed:2459082}. /FTId=VAR_003136."
     Region          26
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="G -> E (in Cosenza; dbSNP:rs35687396).
                     {ECO:0000269|PubMed:1726095}. /FTId=VAR_003137."
     Region          27
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="E -> K (in Oakland; dbSNP:rs35654328).
                     {ECO:0000269|PubMed:2442122}. /FTId=VAR_003139."
     Site            order(31,34..35,38,41,98,100,103,109,112..113,116..117,
                     120,123..125,128..129,132)
                     /site_type="other"
                     /note="tetramer interface [polypeptide binding]"
                     /db_xref="CDD:271276"
     Site            order(32,42..43,64,67..68,71,89,93,97,99,103..104,107,142)
                     /site_type="other"
                     /note="heme binding site [chemical binding]"
                     /db_xref="CDD:271276"
     Region          35
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="V -> I (in Tokyo; dbSNP:rs35885783).
                     {ECO:0000269|PubMed:2581919}. /FTId=VAR_003140."
     Region          37..42
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          39
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="T -> P (in Bonheiden; causes severe hereditary
                     hemolytic anemia; dbSNP:rs35799058).
                     {ECO:0000269|PubMed:15645283}. /FTId=VAR_030497."
     Region          41
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="R -> G (in Veleta; dbSNP:rs34532478).
                     /FTId=VAR_003144."
     Region          41
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="R -> K (in Austell; dbSNP:rs281864892).
                     {ECO:0000269|PubMed:2459083}. /FTId=VAR_020649."
     Region          42
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="F -> S (in TNCY; hemoglobin Cincinnati;
                     dbSNP:rs34878913). {ECO:0000269|PubMed:7741137}.
                     /FTId=VAR_003146."
     Region          44..46
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          45
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="S -> R (in Lodz; dbSNP:rs34017450).
                     {ECO:0000269|PubMed:6814491}. /FTId=VAR_003148."
     Site            45
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163}."
     Site            51
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163}."
     Region          52..56
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Site            53
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163}."
     Region          56
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="M -> R (in Kingston; dbSNP:rs34915311).
                     {ECO:0000269|PubMed:6186522}. /FTId=VAR_003150."
     Region          59..76
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          60
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> E (in Emirates; dbSNP:rs28933078).
                     {ECO:0000269|PubMed:7558873}. /FTId=VAR_003151."
     Region          60
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> Q (in Sacromonte; dbSNP:rs28933078).
                     {ECO:0000269|PubMed:7558873}. /FTId=VAR_003152."
     Site            60
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N6-acetyllysine. {ECO:0000250|UniProtKB:P68871}."
     Region          64
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="H -> L (in TNCY; hemoglobin M-Circleville).
                     {ECO:0000269|PubMed:19065339, ECO:0000269|Ref.3}.
                     /FTId=VAR_025336."
     Region          64
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="H -> Y (in TNCY; hemoglobin Osaka; the presence of
                     a tyrosine causes the formation of a covalent link with
                     heme iron, so that the iron is stabilized in the ferric
                     form; when this occurs methemoglobin is formed, oxygen can
                     no longer bind to heme and cyanosis occurs;
                     dbSNP:rs34474104). {ECO:0000269|PubMed:19065339,
                     ECO:0000269|PubMed:2483933}. /FTId=VAR_003154."
     Site            64
                     /site_type="metal-binding"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Iron (heme distal ligand).
                     {ECO:0000250|UniProtKB:P80044}."
     Region          66
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> N (in Clarke; dbSNP:rs34019507).
                     {ECO:0000269|PubMed:2442123}. /FTId=VAR_003155."
     Region          67
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> Q (in Brooklyn; dbSNP:rs34264694).
                     {ECO:0000269|PubMed:1703138}. /FTId=VAR_003157."
     Region          67
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> R (in Shanghai; dbSNP:rs35481866).
                     {ECO:0000269|PubMed:2579547}. /FTId=VAR_003156."
     Region          68
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="V -> M (in TNCY; hemoglobin Toms River; the side
                     chain of methionine decreases both the affinity of oxygen
                     for binding to the mutant hemoglobin subunit via steric
                     hindrance and the rate at which it does so; the mutant
                     methionine is converted to aspartic acid
                     post-translationally; dbSNP:rs587776864).
                     {ECO:0000269|PubMed:21561349}. /FTId=VAR_065950."
     Region          73
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="G -> R (in Minoo; dbSNP:rs281860594).
                     {ECO:0000269|PubMed:3120456}. /FTId=VAR_020650."
     Region          76
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="I -> T (in LesVos/Waynesboro/Charlotte;
                     dbSNP:rs1061234). {ECO:0000269|PubMed:1714434,
                     ECO:0000269|PubMed:8566966, ECO:0000269|PubMed:8718701}.
                     /FTId=VAR_020651."
     Region          76
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="I -> V (in Coigneres; dbSNP:rs34363111).
                     {ECO:0000269|PubMed:11791877}. /FTId=VAR_030498."
     Region          77..81
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          78
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="H -> R (in Kennestone; dbSNP:rs34150306).
                     {ECO:0000269|PubMed:6192110}. /FTId=VAR_003162."
     Region          81
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="D -> N (in Marietta; dbSNP:rs63751148).
                     /FTId=VAR_020652."
     Region          82..85
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Site            83
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N6-acetyllysine. {ECO:0000250|UniProtKB:P68871}."
     Region          87..95
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          93
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="H -> Y (in TNCY; hemoglobin Fort Ripley;
                     dbSNP:rs35103459). {ECO:0000269|PubMed:2470017}.
                     /FTId=VAR_003166."
     Site            93
                     /site_type="metal-binding"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Iron (heme proximal ligand). {ECO:0000244|PDB:1FDH,
                     ECO:0000244|PDB:4MQJ, ECO:0000244|PDB:4MQK,
                     ECO:0000269|PubMed:881729}."
     Site            94
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="S-nitrosocysteine. {ECO:0000250|UniProtKB:P68871}."
     Region          95
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="D -> N (in Columbus-Ga; dbSNP:rs35812514).
                     {ECO:0000269|PubMed:6186636}. /FTId=VAR_003167."
     Region          102..119
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          102
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="E -> K (in La Grange; dbSNP:rs34876238).
                     {ECO:0000269|PubMed:6206897}. /FTId=VAR_003169."
     Region          105
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> N (in Macedonia-II; dbSNP:rs35717854).
                     {ECO:0000269|PubMed:7713741}. /FTId=VAR_003170."
     Region          106
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="L -> H (in TNCY; hemoglobin F-Brugine/ Feldkirch;
                     lowered affinity for oxygen).
                     {ECO:0000269|PubMed:24502349}. /FTId=VAR_073159."
     Region          118
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="H -> R (in Malta-1; dbSNP:rs36049074).
                     {ECO:0000269|PubMed:5792729}. /FTId=VAR_003171."
     Region          119
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="F -> L (in Calabria; dbSNP:rs35020253).
                     {ECO:0000269|PubMed:10722114}. /FTId=VAR_015740."
     Region          120..122
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          121
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="K -> Q (in Caltech; dbSNP:rs34703519).
                     {ECO:0000269|PubMed:6186635}. /FTId=VAR_003172."
     Region          122
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="E -> K (in Carlton; dbSNP:rs63750021).
                     {ECO:0000269|PubMed:836882}. /FTId=VAR_020653."
     Region          125..142
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Region          126
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="E -> A (in Port-Royal; dbSNP:rs34997902).
                     {ECO:0000269|PubMed:4846278}. /FTId=VAR_003174."
     Region          131
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="W -> G (in Poole; unstable; dbSNP:rs35826780).
                     {ECO:0000269|PubMed:1127124}. /FTId=VAR_003176."
     Site            140
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163}."
     Region          143..146
                     /region_name="Helical region"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000244|PDB:4MQJ}."
     Site            143
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163}."
     Site            144
                     /site_type="modified"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:23186163}."
     Region          147
                     /region_name="Variant"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="H -> Y (in Onoda; O(2) affinity up;
                     dbSNP:rs34807671). {ECO:0000269|PubMed:1703139}.
                     /FTId=VAR_003179."
ORIGIN      
        1 mghfteedka titslwgkvn vedaggetlg rllvvypwtq rffdsfgnls sasaimgnpk
       61 vkahgkkvlt slgdaikhld dlkgtfaqls elhcdklhvd penfkllgnv lvtvlaihfg
      121 keftpevqas wqkmvtgvas alssryh
//

